These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients. Souberbielle JC, Massart C, Brailly-Tabard S, Cormier C, Cavalier E, Delanaye P, Chanson P. Eur J Endocrinol; 2016 Mar; 174(3):315-23. PubMed ID: 26628583 [Abstract] [Full Text] [Related]
3. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V, Torregrosa V. Nefrologia; 2008 Mar; 28 Suppl 3():67-78. PubMed ID: 19018742 [Abstract] [Full Text] [Related]
4. Comparison between a second and a third generation parathyroid hormone assay in hemodialysis patients. Gannagé-Yared MH, Farès C, Ibrahim T, Rahal ZA, Elias M, Chelala D. Metabolism; 2013 Oct; 62(10):1416-22. PubMed ID: 23769129 [Abstract] [Full Text] [Related]
7. Parathyroid hormone reference ranges in healthy individuals classified by vitamin D status. Yalla N, Bobba G, Guo G, Stankiewicz A, Ostlund R. J Endocrinol Invest; 2019 Nov; 42(11):1353-1360. PubMed ID: 31273631 [Abstract] [Full Text] [Related]
8. Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values. Cavalier E, Delanaye P, Vranken L, Bekaert AC, Carlisi A, Chapelle JP, Souberbielle JC. Nephrol Dial Transplant; 2012 May; 27(5):1950-6. PubMed ID: 21940481 [Abstract] [Full Text] [Related]
9. Parathyroid hormone measurement in chronic kidney disease: Impact of inter-method variability on mineral bone disease assessment. White CA, Sarabia S, Collier CP, McCudden C, Holden RM. Clin Biochem; 2021 Aug; 94():62-66. PubMed ID: 33895125 [Abstract] [Full Text] [Related]
10. Parathormone, bone alkaline phosphatase and 25-hydroxyvitamin D status in a large cohort of 1200 children and teenagers. Ladang A, Rousselle O, Huyghebaert L, Bekaert AC, Kovacs S, Le Goff C, Cavalier E. Acta Clin Belg; 2022 Feb; 77(1):4-9. PubMed ID: 32441564 [Abstract] [Full Text] [Related]
12. All 25-hydroxyvitamin D-deficient Indian postmenopausal women do not have secondary hyperparathyroidism. Dixit V, Tripathi RL, Dhanwal DK. Arch Osteoporos; 2018 May 27; 13(1):62. PubMed ID: 29806069 [Abstract] [Full Text] [Related]
13. Influence of four different PTH methods on the classification of chronic kidney disease patients according to the new KDIGO guideline. Ten BE, Van Veen MC, Vervloet MG, Fischer JC, Koopman MG, Van Dam B. Clin Lab; 2012 May 27; 58(7-8):719-24. PubMed ID: 22997972 [Abstract] [Full Text] [Related]
16. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. Souberbielle JC, Cormier C, Kindermans C, Gao P, Cantor T, Forette F, Baulieu EE. J Clin Endocrinol Metab; 2001 Jul 27; 86(7):3086-90. PubMed ID: 11443171 [Abstract] [Full Text] [Related]
17. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Youssef Y, Richards WO, Sekhar N, Kaiser J, Spagnoli A, Abumrad N, Torquati A. Surg Endosc; 2007 Aug 27; 21(8):1393-6. PubMed ID: 17318692 [Abstract] [Full Text] [Related]